These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 2668407)

  • 21. Metabolic effects of spirapril and atenolol: results from a randomized, long-term study.
    Hakamäki T; Lehtonen A
    Int J Clin Pharmacol Ther; 1997 Jun; 35(6):227-30. PubMed ID: 9208336
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of atenolol and diltiazem-SR on exercise and pressure load in hypertensive patients.
    Chrysant SG; Miller E
    Clin Cardiol; 1994 Dec; 17(12):670-4. PubMed ID: 7867240
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Urapidil treatment decreases plasma fibrinogen concentration in essential hypertension.
    Haenni A; Lithell H
    Metabolism; 1996 Oct; 45(10):1221-9. PubMed ID: 8843176
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metabolic outcome during 1 year in newly detected hypertensives: results of the Antihypertensive Treatment and Lipid Profile in a North of Sweden Efficacy Evaluation (ALPINE study).
    Lindholm LH; Persson M; Alaupovic P; Carlberg B; Svensson A; Samuelsson O
    J Hypertens; 2003 Aug; 21(8):1563-74. PubMed ID: 12872052
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Induction of insulin resistance by beta-blockade but not ACE-inhibition: long-term treatment with atenolol or trandolapril.
    Reneland R; Alvarez E; Andersson PE; Haenni A; Byberg L; Lithell H
    J Hum Hypertens; 2000 Mar; 14(3):175-80. PubMed ID: 10694831
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term effects of doxazosin and atenolol on serum lipids and blood pressure in hypertensive smokers.
    Talseth T; Westlie L; Daae LN
    J Hypertens Suppl; 1990 Sep; 8(5):S47-51. PubMed ID: 1981077
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and safety of bisoprolol and atenolol in patients with mild to moderate hypertension: a double-blind, parallel group international multicentre study.
    Lithell H; Selinus I; Hosie J; Frithz G; Weiner L
    Eur Heart J; 1987 Dec; 8 Suppl M():55-64. PubMed ID: 2967186
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of bunazosin and atenolol on glucose metabolism in obese, nondiabetic patients with primary hypertension.
    Bönner G; Schmieder R; Chrosch R; Weidinger G
    Cardiovasc Drugs Ther; 1997 Mar; 11(1):21-6. PubMed ID: 9140673
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of diltiazem on serum lipids, exercise performance and blood pressure: randomized, double-blind, placebo-controlled evaluation for systemic hypertension.
    Pool PE; Seagren SC; Salel AF
    Am J Cardiol; 1985 Dec; 56(16):86H-91H. PubMed ID: 3907322
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative effects of diltiazem sustained-release formulation and metoprolol on ambulatory blood pressure and plasma lipoproteins.
    Lacourcière Y; Poirier L; Boucher S; Spenard J
    Clin Pharmacol Ther; 1990 Sep; 48(3):318-24. PubMed ID: 2401129
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diltiazem in hypertensive patients with type II diabetes mellitus.
    Andrén L; Höglund P; Dotevall A; Eggertsen R; Svensson A; Olson SO; Wadenvik H
    Am J Cardiol; 1988 Oct; 62(11):114G-120G. PubMed ID: 3177228
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Insulin sensitivity in newly detected hypertensive patients: influence of captopril and other antihypertensive agents on insulin sensitivity and related biological parameters.
    Lithell HO; Pollare T; Berne C
    J Cardiovasc Pharmacol; 1990; 15 Suppl 5():S46-52. PubMed ID: 1694931
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of the effects of doxazosin and atenolol on blood pressure and blood lipids: a one-year, double-blind study in 228 hypertensive patients.
    Talseth T; Westlie L; Daae L; Vatle S
    Am Heart J; 1988 Dec; 116(6 Pt 2):1790-6. PubMed ID: 2904752
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lipids and lipoproteins during antihypertensive drug therapy. Comparison of doxazosin and atenolol in a randomized, double-blind trial: the Alpha Beta Canada Study.
    Rabkin SW; Huff MW; Newman C; Sim D; Carruthers SG
    Hypertension; 1994 Aug; 24(2):241-8. PubMed ID: 8039850
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metabolic effects of controlled-release metoprolol in hypertensive men with impaired or diabetic glucose tolerance: a comparison with atenolol.
    Fagerberg B; Berglund A; Holme E; Wilhelmsen L; Elmfeldt D
    J Intern Med; 1990 Jan; 227(1):37-43. PubMed ID: 2405089
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of sympatholytic therapy on insulin sensitivity indices in hypertensive postmenopausal women.
    Kaaja R; Kujala S; Manhem K; Katzman P; Kibarskis A; Antikainen R; Ylihärsilä H; Erkkola R; Tuomilehto J
    Int J Clin Pharmacol Ther; 2007 Jul; 45(7):394-401. PubMed ID: 17725246
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment with a beta-blocker with beta 2-agonism improves glucose and lipid metabolism in essential hypertension.
    Haenni A; Lithell H
    Metabolism; 1994 Apr; 43(4):455-61. PubMed ID: 8159103
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A randomized controlled trial of the effects of three antihypertensive agents on blood pressure control and quality of life in older women.
    Applegate WB; Phillips HL; Schnaper H; Shepherd AM; Schocken D; Luhr JC; Koch GG; Park GD
    Arch Intern Med; 1991 Sep; 151(9):1817-23. PubMed ID: 1888248
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metabolic and antihypertensive effects of moxonidine and moxonidine plus irbesartan in patients with type 2 diabetes mellitus and mild hypertension: a sequential, randomized, double-blind clinical trial.
    Derosa G; Cicero AF; D'Angelo A; Fogari E; Salvadeo S; Gravina A; Ferrari I; Fassi R; Fogari R
    Clin Ther; 2007 Apr; 29(4):602-10. PubMed ID: 17617283
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Insulin sensitivity in obese hypertensive dyslipidemic patients treated with enalapril or atenolol.
    Morel Y; Gadient A; Keller U; Vadas L; Golay A
    J Cardiovasc Pharmacol; 1995 Aug; 26(2):306-11. PubMed ID: 7475056
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.